ARPA-H invests $160 million to make custom gene editing routine
ARPA-H, the U.S.’ “moonshot” agency for health research, announced Thursday that it will spend up to $160 million…
How one father built a biotech, Grace Science, to save his daughter
Highlights Matt Wilsey has spent a decade and $70 million trying to develop a cure for his daughter…
New gene therapy strategy uses the brain’s own glymphatic transport system for drug delivery
A new study describes a gene therapy strategy that uses the brain’s own glymphatic transport system to distribute…
Molecular changes in the liver of space travelers provide clues about aging
What happens to the human body in space may help scientists create new anti-aging therapies. UCF’s Michal Masternak…
Green synthesis of gold nanoparticles utilizing Raphanus sativus root extract: characterization and in vitro investigation of its antioxidant, antimicrobial and anticancer impact
The special phytochemical composition of RRR water extract causes the formation of the envelope surrounding gold metal atom…
Colorado’s first-of-its-kind price cap on an Amgen drug blocked
Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
Smart prodrug targets Alzheimer’s disease using hydrogen peroxide signals
A substance that worsens dementia has become a “switch” that initiates treatment. KAIST researchers have developed a new…
Screwworm could be the first species targeted by an ‘extinction drive’
Tusk-like mandibles protrude from a screwworm larva’s mouth Scott Camazine/Alamy In a few cases, the extinction of a…
Anthropic releases Claude Science, sees Claude Code level impact
Brittany Trang, Ph.D., covers AI in health and medicine: Does it actually work? Who benefits, or might be…
Medicare obesity drug GLP-1 coverage starting July 1
Millions of older Americans in Medicare are about to receive a benefit that has never existed before: coverage…
Abivax aims to ease safety concerns with new ulcerative colitis data
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially…
China, Shanghai, AI hair growth drug, Eli Lilly: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…